Description

Latvia Pharmaceuticals and Healthcare Report Q2 2015 Description

BMI View: Market growth forecasts are strong although the country will continue to present a modestopportunity to larger multinational companies on account of its relatively small market size. Meanwhile,tensions between Ukraine and Russia may provide challenges for local manufacturers that had soughtexports to Russia and the Commonwealth of Independent States (CIS) region as a remedy for lacklustredomestic demand in recent years.

Headline Expenditure Projections

Pharmaceuticals: EUR340mn (USD456mn) in 2014 to EUR360mn (USD449mn) in 2015; +5.6% inlocal currency terms and -1.5% in US dollar terms.

Healthcare: EUR0.98bn (USD1.31bn) in 2014 to EUR1.02bn (USD1.27bn) in 2015; +4.1% in localcurrency terms and -2.8% in US dollar terms.